Anal Fistula Surgical Treatment Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI4295
Anal fistula surgical treatment size is expected to grow significantly from 2019 to 2025.
The anal fistula surgical treatment market is projected to witness lucrative growth over the coming years due to the increasing prevalence of inflammatory bowel diseases. Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal (GI) tract that includes both ulcerative colitis and crohn disease. Some of the symptoms of inflammatory bowel diseases are diarrhea, reduced appetite, unintended weight loss, abdominal pain and cramping, and others.
The introduction of novel treatment techniques has further contributed to the market growth. For instance, cell therapy for an anal fistula was introduced for the regeneration or the repair of damaged tissues. Adipose-derived stem cells have two biologic properties, namely, differentiation potential and the ability to suppress inflammation. The treatment for anal fistula is usually associated with low recurrence rates and minimal incontinence. Minimally invasive treatments have been emerged in recent years using a specially designed fistuloscope. However, high cost associated with the surgeries and risk of a change in continence with conventional techniques might hamper the growth rate of anal fistula surgical treatment market over the forecast period. Furthermore, complications of surgery like recurrence, infection, and bowel incontinence might also reduce the adoption of anal fistula treatment. Patients are likely to suffer from some pain following the anal fistula surgical procedure.
The fistulotomy treatment segment should witness significant growth during the forthcoming years. Fistulotomy is the most common and effective type of procedure amongst all the surgical procedures for anal fistula. In this procedure, an incision is made along the whole length of the fistula, from the internal to the external opening. Depending on the location, a small portion of the anal sphincter might need to be cut to gain access to the fistula.
Intersphincteric fistula segment marked a significant revenue share in 2018 and is projected to follow a similar trend during the forecast period. This is majorly due to the increasing prevalence of submucosal anal fistulae globally.
Asia Pacific anal fistula surgical treatment market is anticipated to grow rapidly over the coming years. This is majorly due to the adoption of traditional methods like fistulotomy and setons in the rural areas of the region. Furthermore, the growing prevalence of inflammatory bowel diseases in the region also possesses a demand for anal fistula surgical treatment. For this, various government initiatives are taking place to increase awareness through effective education, communication, and training.
Some of the notable hospitals operating in the anal fistula surgical treatment market are Renacres Hospital, Stanford Health Care, St. Mark's Hospital, HCA Healthcare, Alberta Health Services, Apollo Hospitals Enterprise Ltd., Fortis Healthcare, Royal Prince Alfred Hospital, Sikarin Hospital, and Bumrungrad International Hospital. Increasing funding and research for inflammatory bowel diseases in various universities to reduce the disease burden, is driving the manufacturer's attention to increase their product footprint in the anal fistula surgical treatment market. For instance, in 2018, the University of Houston in the US received a USD 347,490 grant from the Crohn’s & Colitis Foundation of America. In May 2018, a study comparing the efficiency of newer biologic and small-molecule therapies for inflammatory bowel disease received a funding of USD 2.4 million grant from the Crohn’s & Colitis Foundation and the Patient-Centered Outcomes Research Institute.
Anal Fistula Surgical Treatment Market By Treatment type, 2014-2025 (USD Million)
- Seton techniques
- Advancement flap procedures
- Bioprosthetic plug
Anal Fistula Surgical Treatment Market By Anal fistula type, 2014-2025 (USD Million)
- Intersphincteric fistula
- Transphincteric fistula
- Suprasphincteric fistula
- Extrasphincteric fistula
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- GCC Countries
- Renacres Hospital
- Stanford Health Care
- St. Mark's Hospital
- HCA Healthcare
- Alberta Health Services
- Apollo Hospitals Enterprise Ltd.
- Fortis Healthcare
- Sikarin Hospital
- Bumrungrad International Hospital
- Royal Prince Alfred Hospital
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.